
Patricia Ann Duffy
Examiner (ID: 7333)
| Most Active Art Unit | 1645 |
| Art Unit(s) | 1806, 1648, 1802, 1645, 1818 |
| Total Applications | 1671 |
| Issued Applications | 766 |
| Pending Applications | 244 |
| Abandoned Applications | 672 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 7662319
[patent_doc_number] => 20110311588
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-22
[patent_title] => 'AGENTS AND TREATMENT FOR SNORING AND RESPIRATORY EFFORT RELATED AROUSALS IN SLEEP'
[patent_app_type] => utility
[patent_app_number] => 13/129034
[patent_app_country] => US
[patent_app_date] => 2009-11-09
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 1
[patent_figures_cnt] => 1
[patent_no_of_words] => 6271
[patent_no_of_claims] => 16
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0311/20110311588.pdf
[firstpage_image] =>[orig_patent_app_number] => 13129034
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/129034 | AGENTS AND TREATMENT FOR SNORING AND RESPIRATORY EFFORT RELATED AROUSALS IN SLEEP | Nov 8, 2009 | Abandoned |
Array
(
[id] => 6314209
[patent_doc_number] => 20100111953
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-06
[patent_title] => 'ANTIBODIES THAT IMMUNOSPECIFICALLY BIND TO B LYMPHOCYTE STIMULATOR'
[patent_app_type] => utility
[patent_app_number] => 12/605202
[patent_app_country] => US
[patent_app_date] => 2009-10-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 200904
[patent_no_of_claims] => 71
[patent_no_of_ind_claims] => 12
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20100111953.pdf
[firstpage_image] =>[orig_patent_app_number] => 12605202
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/605202 | ANTIBODIES THAT IMMUNOSPECIFICALLY BIND TO B LYMPHOCYTE STIMULATOR | Oct 22, 2009 | Abandoned |
Array
(
[id] => 7817494
[patent_doc_number] => 20120064114
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2012-03-15
[patent_title] => 'USE OF E. COLI SURFACE ANTIGEN 3 SEQUENCES FOR THE EXPORT OF HETEROLOGOUS ANTIGENS'
[patent_app_type] => utility
[patent_app_number] => 13/125533
[patent_app_country] => US
[patent_app_date] => 2009-10-21
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 22153
[patent_no_of_claims] => 25
[patent_no_of_ind_claims] => 9
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0064/20120064114.pdf
[firstpage_image] =>[orig_patent_app_number] => 13125533
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/125533 | USE OF E. COLI SURFACE ANTIGEN 3 SEQUENCES FOR THE EXPORT OF HETEROLOGOUS ANTIGENS | Oct 20, 2009 | Abandoned |
Array
(
[id] => 7987171
[patent_doc_number] => 08075879
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2011-12-13
[patent_title] => 'Brucella melitensis mutants and methods'
[patent_app_type] => utility
[patent_app_number] => 12/580213
[patent_app_country] => US
[patent_app_date] => 2009-10-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 16
[patent_no_of_words] => 15789
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 52
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/08/075/08075879.pdf
[firstpage_image] =>[orig_patent_app_number] => 12580213
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/580213 | Brucella melitensis mutants and methods | Oct 14, 2009 | Issued |
Array
(
[id] => 7510066
[patent_doc_number] => 20110256172
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-20
[patent_title] => 'EPITOPE-TARGETED ANTHRAX VACCINE'
[patent_app_type] => utility
[patent_app_number] => 13/124167
[patent_app_country] => US
[patent_app_date] => 2009-10-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 27
[patent_figures_cnt] => 27
[patent_no_of_words] => 20648
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0256/20110256172.pdf
[firstpage_image] =>[orig_patent_app_number] => 13124167
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/124167 | EPITOPE-TARGETED ANTHRAX VACCINE | Oct 13, 2009 | Abandoned |
Array
(
[id] => 6637151
[patent_doc_number] => 20100173842
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-07-08
[patent_title] => 'VACCINE FOR STAPHYLOCOCCAL INFECTIONS'
[patent_app_type] => utility
[patent_app_number] => 12/575667
[patent_app_country] => US
[patent_app_date] => 2009-10-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 4
[patent_figures_cnt] => 4
[patent_no_of_words] => 6162
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0173/20100173842.pdf
[firstpage_image] =>[orig_patent_app_number] => 12575667
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/575667 | VACCINE FOR STAPHYLOCOCCAL INFECTIONS | Oct 7, 2009 | Abandoned |
Array
(
[id] => 7657482
[patent_doc_number] => 20110306751
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-12-15
[patent_title] => 'Independently Inducible System of Gene Expression'
[patent_app_type] => utility
[patent_app_number] => 13/122547
[patent_app_country] => US
[patent_app_date] => 2009-10-05
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 14300
[patent_no_of_claims] => 33
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0306/20110306751.pdf
[firstpage_image] =>[orig_patent_app_number] => 13122547
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/122547 | Independently Inducible System of Gene Expression | Oct 4, 2009 | Abandoned |
Array
(
[id] => 6574364
[patent_doc_number] => 20100129349
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-27
[patent_title] => 'Methods of inhibiting staphylobactin-mediated iron uptake in S. aureus'
[patent_app_type] => utility
[patent_app_number] => 12/588067
[patent_app_country] => US
[patent_app_date] => 2009-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 15
[patent_figures_cnt] => 15
[patent_no_of_words] => 31547
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0129/20100129349.pdf
[firstpage_image] =>[orig_patent_app_number] => 12588067
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/588067 | Methods of inhibiting staphylobactin-mediated iron uptake in S. aureus | Oct 1, 2009 | Abandoned |
Array
(
[id] => 7487552
[patent_doc_number] => 20110236425
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-29
[patent_title] => 'ANTHRAX VACCINE FORMULATION AND USES THEREOF'
[patent_app_type] => utility
[patent_app_number] => 12/998245
[patent_app_country] => US
[patent_app_date] => 2009-10-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 4132
[patent_no_of_claims] => 26
[patent_no_of_ind_claims] => 7
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0236/20110236425.pdf
[firstpage_image] =>[orig_patent_app_number] => 12998245
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/998245 | Anthrax vaccine formulation and uses thereof | Oct 1, 2009 | Issued |
Array
(
[id] => 6550437
[patent_doc_number] => 20100233179
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-09-16
[patent_title] => 'BAFF, inhibitors thereof and their use in the modulation of B-cell response'
[patent_app_type] => utility
[patent_app_number] => 12/570518
[patent_app_country] => US
[patent_app_date] => 2009-09-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 31
[patent_figures_cnt] => 31
[patent_no_of_words] => 15671
[patent_no_of_claims] => 36
[patent_no_of_ind_claims] => 22
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0233/20100233179.pdf
[firstpage_image] =>[orig_patent_app_number] => 12570518
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/570518 | BAFF, inhibitors thereof and their use in the modulation of B-cell response | Sep 29, 2009 | Abandoned |
Array
(
[id] => 6314362
[patent_doc_number] => 20100111978
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-06
[patent_title] => 'CONJUGATES BETWEEN A VARIANT STAPHYLOCOCCAL ENTEROTOXIN E SUPERANTIGEN AND A TARGETING ANTIBODY THAT BINDS TO A CANCER-ASSOCIATED CELL SURFACE STRUCTURE'
[patent_app_type] => utility
[patent_app_number] => 12/568579
[patent_app_country] => US
[patent_app_date] => 2009-09-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 11
[patent_figures_cnt] => 11
[patent_no_of_words] => 17358
[patent_no_of_claims] => 59
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0111/20100111978.pdf
[firstpage_image] =>[orig_patent_app_number] => 12568579
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/568579 | CONJUGATES BETWEEN A VARIANT STAPHYLOCOCCAL ENTEROTOXIN E SUPERANTIGEN AND A TARGETING ANTIBODY THAT BINDS TO A CANCER-ASSOCIATED CELL SURFACE STRUCTURE | Sep 27, 2009 | Abandoned |
Array
(
[id] => 7695942
[patent_doc_number] => 20110230648
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-09-22
[patent_title] => 'METHOD OF BINDING BACTERIAL LIPOPOLYSACCHARIDES TO A SOLID PHASE'
[patent_app_type] => utility
[patent_app_number] => 13/059539
[patent_app_country] => US
[patent_app_date] => 2009-09-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4135
[patent_no_of_claims] => 3
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0230/20110230648.pdf
[firstpage_image] =>[orig_patent_app_number] => 13059539
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/059539 | Method of binding bacterial lipopolysaccharides to a solid phase | Sep 26, 2009 | Issued |
Array
(
[id] => 6304506
[patent_doc_number] => 20100068753
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-18
[patent_title] => 'Biotin-facilitated transport in gram negative bacteria'
[patent_app_type] => utility
[patent_app_number] => 12/584875
[patent_app_country] => US
[patent_app_date] => 2009-09-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 10
[patent_figures_cnt] => 10
[patent_no_of_words] => 9915
[patent_no_of_claims] => 17
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0068/20100068753.pdf
[firstpage_image] =>[orig_patent_app_number] => 12584875
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/584875 | Biotin-facilitated transport in gram negative bacteria | Sep 13, 2009 | Abandoned |
Array
(
[id] => 6007067
[patent_doc_number] => 20110059098
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-03-10
[patent_title] => 'Human Anthrax Toxin Neutralizing Monoclonal Antibodies and Methods of Use Thereof'
[patent_app_type] => utility
[patent_app_number] => 12/555701
[patent_app_country] => US
[patent_app_date] => 2009-09-08
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 14
[patent_figures_cnt] => 14
[patent_no_of_words] => 15607
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 6
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0059/20110059098.pdf
[firstpage_image] =>[orig_patent_app_number] => 12555701
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/555701 | Human Anthrax Toxin Neutralizing Monoclonal Antibodies and Methods of Use Thereof | Sep 7, 2009 | Abandoned |
Array
(
[id] => 6616733
[patent_doc_number] => 20100003259
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-01-07
[patent_title] => 'ANTIBODIES THAT IMMUNOSPECIFICALLY BIND TO B LYMPHOCYTE STIMULATOR PROTEIN'
[patent_app_type] => utility
[patent_app_number] => 12/552915
[patent_app_country] => US
[patent_app_date] => 2009-09-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 16
[patent_figures_cnt] => 16
[patent_no_of_words] => 179906
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0003/20100003259.pdf
[firstpage_image] =>[orig_patent_app_number] => 12552915
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/552915 | Antibodies that immunospecifically bind to B lymphocyte stimulator protein | Sep 1, 2009 | Issued |
Array
(
[id] => 8066107
[patent_doc_number] => 20110243969
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2011-10-06
[patent_title] => 'PRODUCTION OF SQUALENE FROM HYPER-PRODUCING YEASTS'
[patent_app_type] => utility
[patent_app_number] => 13/061505
[patent_app_country] => US
[patent_app_date] => 2009-08-28
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4699
[patent_no_of_claims] => 22
[patent_no_of_ind_claims] => 20
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0243/20110243969.pdf
[firstpage_image] =>[orig_patent_app_number] => 13061505
[rel_patent_id] =>[rel_patent_doc_number] =>) 13/061505 | Production of squalene from hyper-producing yeasts | Aug 27, 2009 | Issued |
Array
(
[id] => 6220039
[patent_doc_number] => 20100055134
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-03-04
[patent_title] => 'Method of separating protective components of bordetella pertussis'
[patent_app_type] => utility
[patent_app_number] => 12/461925
[patent_app_country] => US
[patent_app_date] => 2009-08-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9162
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 4
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0055/20100055134.pdf
[firstpage_image] =>[orig_patent_app_number] => 12461925
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/461925 | Method of separating protective components of bordetella pertussis | Aug 26, 2009 | Abandoned |
Array
(
[id] => 4677
[patent_doc_number] => 07816494
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2010-10-19
[patent_title] => 'SdrC protein from Staphylococcus aureus and diagnostic kits including same'
[patent_app_type] => utility
[patent_app_number] => 12/546268
[patent_app_country] => US
[patent_app_date] => 2009-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 38
[patent_no_of_words] => 19664
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 18
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] => patents/07/816/07816494.pdf
[firstpage_image] =>[orig_patent_app_number] => 12546268
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/546268 | SdrC protein from Staphylococcus aureus and diagnostic kits including same | Aug 23, 2009 | Issued |
Array
(
[id] => 6377666
[patent_doc_number] => 20100081616
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-04-01
[patent_title] => 'EXTRACELLULAR MATRIX-BINDING PROTEINS FROM STAPHYLOCOCCUS AUREUS'
[patent_app_type] => utility
[patent_app_number] => 12/546289
[patent_app_country] => US
[patent_app_date] => 2009-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 19661
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0081/20100081616.pdf
[firstpage_image] =>[orig_patent_app_number] => 12546289
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/546289 | SDRD protein from Staphylococcus aureus and diagnostic kits including same | Aug 23, 2009 | Issued |
Array
(
[id] => 6320390
[patent_doc_number] => 20100113349
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2010-05-06
[patent_title] => 'EXTRACELLULAR MATRIX-BINDING PROTEINS FROM STAPHYLOCOCCUS AUREUS'
[patent_app_type] => utility
[patent_app_number] => 12/546322
[patent_app_country] => US
[patent_app_date] => 2009-08-24
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 34
[patent_figures_cnt] => 34
[patent_no_of_words] => 19654
[patent_no_of_claims] => 15
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 0
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] => publications/A1/0113/20100113349.pdf
[firstpage_image] =>[orig_patent_app_number] => 12546322
[rel_patent_id] =>[rel_patent_doc_number] =>) 12/546322 | SDRE protein from Staphylococcus aureus and diagnostic kits including same | Aug 23, 2009 | Issued |